Clinical Trials Directory

Trials / Completed

CompletedNCT04584801

SLP Model Development in the Diagnosis of COPD Patients

A Comparative, Multi Centre Study, to Develop a Model for Structured Light Plethysmography Against Standard of Care in the Diagnosis of Chronic Obstructive Pulmonary Disease for Patients Who Plan to Undergo Spirometry Testing

Status
Completed
Phase
Study type
Observational
Enrollment
201 (actual)
Sponsor
Pneumacare Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is an observational, comparative, multicentre study to develop a model for the Thora3Di™ against standard practice in patients who are undergoing investigation for COPD. The core methodology involves capturing of data during a short period of measurement of breathing using SLP against spirometric outcomes.

Detailed description

This study will generate data to characterise the tidal breathing patterns and parameters with Thora-3Di™ against spirometry FEV1/FVC and %predicted. Subjects will have a Part A visit (Development Phase) to develop algorithms for COPD diagnosis. At Part A visit, subjects will have two 5-minute SLP measurements (Pre and Post bronchodilator). The SLP measurement should be performed prior to standard lung function tests with minimal impact on clinical time and no change to hospital attendance. Also, subjects will be asked to report concomitant medications and adverse events and fill in COPD assessment test (CAT™).

Conditions

Interventions

TypeNameDescription
DEVICEStructured Light PlethysmographyDevelopment Phase (Original Part A): Participants will have two 5-minute SLP measurements (Pre and Post bronchodilator). Participants will also undergo standard of care spirometry assessment

Timeline

Start date
2021-05-05
Primary completion
2023-06-15
Completion
2023-06-15
First posted
2020-10-14
Last updated
2024-09-19

Locations

7 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04584801. Inclusion in this directory is not an endorsement.